Rubius is a Massachusetts-based biopharmaceutical company that develops and commercializes cellular therapies for the treatment of cancer and autoimmune diseases.
Business Model:
Revenue: $0
Employees: 201-500
Address: 399 Binney Street
City: Cambridge
State: MA
Zip: 02139
Country: US
Rubius is a Massachusetts-based biopharmaceutical company that develops and commercializes cellular therapies for the treatment of cancer and autoimmune diseases.
Contact Phone:
+16176799600
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
7/18/2018
IPO Valuation:
$2B
Ticker Symbol:
RUBY
IPO Price:
$23/share
Amount Raised:
$241M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 3/2021 | Post-IPO Equity | $200M | 7/2018 | IPO | $241.1M | 12/2018 | Post-IPO Debt | $25M |
Solar Capital Partners |
2/2018 | Series C | $100M | 6/2017 | Series B | 1 | $120M |
Flagship Pioneering Flagship Pioneering Flagship Pioneering Flagship Pioneering |
3/2018 | Series C | 1 | $100M |
Flagship Pioneering Flagship Pioneering Flagship Pioneering Flagship Pioneering |
12/2015 | Series A | 1 | $25M |
Flagship Pioneering Flagship Pioneering Flagship Pioneering Flagship Pioneering |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|